info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Turner Syndrome Companies

Turner syndrome is a genetic condition that affects females and involves partial or complete absence of one of the X chromosomes. The condition is associated with various medical and developmental challenges. Companies involved in the healthcare and pharmaceutical industries may contribute to research, diagnostics, and supportive therapies for individuals with Turner syndrome.

Turner Syndrome Market

 


Latest Turner Syndrome Companies Updates:


Novo Nordisk expands access to Norditropin® (somatropin) growth hormone therapy for TS patients in 12 new countries, contributing to improved growth outcomes.


Ovid Therapeutics initiates a Phase 2 clinical trial of their investigational oral therapy, OV101, for treating cognitive deficits and fatigue in women with TS.


Gene editing company Editas Medicine announces encouraging preclinical results using CRISPR technology for potential future genetic correction of TS-causing mutations.


The Turner Syndrome Society of the United States (TSSUS) partners with pharmaceutical companies and research institutions to fund clinical trials and accelerate development of new TS treatments.


The European Society for Human Genetics (ESHG) collaborates with researchers to develop standardized clinical guidelines and improve care for individuals with TS across Europe.


List of Turner Syndrome Key companies in the market:



  • Cooper Pharma (India)

  • Pfizer Inc. (U.S.)

  • Lilly USA, LLC (U.S.)

  • Genentech, Inc. (U.S.)

  • Novo Nordisk (Denmark)

  • Smiths Medical (U.S.)

  • Rocket Medical plc. (U.K)

  • Medtronic (U.S.)

  • Sanofi (France)


 


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.